Loading quotes...

Forecast

The analysts' average price target is €30.54 (+78.60%). The median is €30.54 (+78.60%).

Buy	1
Hold	1
Sell	1

News Go to news feed

ATS announces margin offensive and focuses portfolio on life sciences

At the Jefferies Global Industrials Conference, ATS presented a plan to raise its EBIT margin to 15% and expects long-term margins in the high teens. About 50% of revenue now comes from the life-sciences business; the company aims to achieve margin improvements roughly half through fixed-cost transformation and an internal efficiency program and partly via aftermarket services and the ATS business model. Key growth areas are life sciences, radiopharmaceuticals, personalized medicine and nuclear technology; M&A to strengthen the portfolio remains planned. Management cited risks from project timelines, macroeconomic uncertainty and execution; investors will watch progress on the fixed-cost transformation, aftermarket growth and the ability to integrate future acquisitions. » More on de.investing.com
ATS reports net loss and revenue decline, shares sharply lower pre-market

ATS recorded a net loss of C$0.3m in the first fiscal quarter of 2027 versus a profit of C$24.3m a year earlier, and revenues fell 5.8% to C$693.7m. Management announced an 18-month "Fixed Cost Transformation Program" and conceded that significant efforts are required to meet margin targets. Adjusted EPS of $0.35 and adjusted EBITDA of C$92.9m beat expectations but could not offset selling pressure and a roughly 5.5% pre-market share decline. » More on de.investing.com
Moody’s raises rating of ATS Corporation after rapid debt reduction

Moody’s has upgraded ATS Corporation’s Corporate Family Rating from Ba3 to Ba2 and its Probability of Default rating to Ba2-PD; the senior unsecured debt rating was raised to Ba3. The move is based on a significant debt reduction over the past 12 months, a recovery in EBITDA, higher free cash flows including a one-time payment, and a lower financing need for acquisitions. Moody’s expects the leverage ratio to fall below 3.5x by the end of fiscal 2027 and notes positive diversification effects in life sciences and energy. Remaining risks include debt re-leveraging from acquisitions, cyclical order volatility, and the company’s comparatively small size. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2022, ATS Corporation has already paid €0.88 in dividends. The last payout was in February 2022.

Financials

In the last quarter, ATS Corporation had revenue of €427.82m and net profit of -€190.56k

(EUR)	June 2026	YoY
Revenue	427.82m	6.87%
Gross profit	117.14m	14.55%
Net profit	-190.56k	101.27%
EBITDA	40.05m	32.56%

Fundamentals

Metric	Value
Market capitalization	€1.67bn
Number of shares	98.13m
52-week high/low	€32.18 - €15.41
Dividends	No
Beta	1.12
P/E ratio	54.80
PEG ratio	0.02
P/B ratio	1.45
P/S ratio	0.89

Company profile

ATS Corporation, together with its subsidiaries, provides automation solutions worldwide. The company is also involved in the planning, designing, building, commissioning, and servicing automated manufacturing and assembly systems, including automation products and test solutions. It offers enterprise solutions in the areas of project management; partners/suppliers/vendors team selection and coordination; facility layouts and operational design; business case development and project justification; post project service, spare parts, and support; and system design, built, integration, commissioning, validation, training and start up. In addition, the company offers pre-automation services comprising discovery and analysis, concept development, simulation, and total cost of ownership modelling; post automation services, including training, process optimization, preventative maintenance, emergency and on-call support, spare parts, retooling, retrofits, and equipment relocation; and contract manufacturing services. Further, it provides engineering design, prototyping, process verification, specification writing, software and manufacturing process controls development, standard automation products/platforms, equipment design and build, third-party equipment qualification, procurement and integration, automation system installation, product line commissioning, validation, and documentation services. The company serves life sciences, transportation, consumer products, food and beverage, and energy markets. The company was formerly known as ATS Automation Tooling Systems Inc. and changed its name to ATS Corporation in November 2022. ATS Corporation was founded in 1978 and is headquartered in Cambridge, Canada.